Inside of a the latest review, we reported the identification and also the characterization of a new atypical opioid receptor with special adverse regulatory properties to opioid peptides.1 Our outcomes confirmed that ACKR3/CXCR7, hitherto referred to as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is also a wide-spectrum scaven